Oramed to Present at the American Diabetes Association 78th Scientific Sessions
NEW YORK, June 12, 2018 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that three scientific abstracts will be presented as posters at the ADA 78th Scientific Sessions on June 22-25, 2018 in Orlando, Florida. The posters will be […]
